A 340B anti-discrimination bill targeting pharmacy benefit managers and drug manufacturers failed to advance in Connecticut.
State Bill That Would Have Stopped Drug Industry from Imposing 340B Contract Pharmacy Restrictions Dies
Legislation in Connecticut that would have kept drug manufacturers from imposing “any preconditions, limitations, delays or other barriers” to 340B drug purchases “that are not required” by the 340B statute, died when this year’s legislative session ended on May 4.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.